162,856,795 shares: 0708.HK China Evergrande NEV (HKSE) intraday 25 Mar 2026

Intraday trading in Hong Kong has pushed 0708.HK stock into the most-active list as volume spikes to 162,856,795.00 shares on 25 Mar 2026. The counter trades at HKD 0.17, up 1.19% from the prior close, while the 50-day average sits near HKD 0.18 and the 200-day average at HKD 0.26. This note covers price action, fundamentals, Meyka AI grade and a model forecast to frame short-term trading and risk.

Intraday price and volume action for 0708.HK stock

The stock opened at HKD 0.17 and reached a day high of HKD 0.21 on heavy turnover of 162,856,795.00 shares, roughly 4.99 times average volume. This single-day volume surge is the primary driver of the intraday move and reflects a concentrated trading interest in China Evergrande New Energy Vehicle Group Limited on the HKSE.

Fundamentals and valuation snapshot for 0708.HK stock

China Evergrande NEV reports EPS -2.65 and an accounting PE of -0.06, with market capitalisation near HKD 1,843,444,864.00. Key metrics show negative book value per share and strained cash metrics, including cash per share HKD 0.01 and current ratio 0.34, signalling weak liquidity versus healthcare sector averages in Hong Kong.

Technical context and moving averages for 0708.HK stock

Price sits below the 200-day average (HKD 0.26) and roughly in line with the 50-day average (HKD 0.18), a setup that favours range trading rather than trend following. Relative volume and the intraday high at HKD 0.21 create short-term resistance and support reference points for traders, while the stock’s year high is HKD 0.81 and year low HKD 0.12.

Meyka AI grade, forecast and price-target framing for 0708.HK stock

Meyka AI rates 0708.HK with a score out of 100: 64.37, Grade B, Suggestion: HOLD. This grade factors S&P 500 and sector comparisons, financial growth, metrics and analyst consensus. Meyka AI’s forecast model projects HKD 0.12 for 0708.HK stock, implying -29.41% versus the current HKD 0.17; forecasts are model-based projections and not guarantees.

Risks, catalysts and sector context for 0708.HK stock

Primary risks include continued liquidity pressure, negative earnings trends and parent-group legacy issues that can affect sentiment. Catalysts that could lift the stock include any confirmed capital injections, clearer NEV unit deliveries or improved cash metrics. Healthcare sector performance in Hong Kong shows a 1-day move of 2.53%, but China Evergrande NEV’s mixed business mix ties it to both healthcare and EV cycles.

Trading notes and realistic price targets for 0708.HK stock

For intraday and short-term traders, watch HKD 0.21 as resistance and HKD 0.17 as immediate support; a close above HKD 0.21 with follow-through volume could test HKD 0.25. Meyka frames a conservative price target at HKD 0.10 (high-risk scenario) and a recovery target at HKD 0.25 (positive catalyst case). Position sizing should reflect high volatility and low liquidity on some sessions.

Final Thoughts

0708.HK stock is trading as one of Hong Kong’s most-active counters on 25 Mar 2026, led by a concentrated volume wave of 162,856,795.00 shares and a current mid-price of HKD 0.17. Fundamentals remain challenged with EPS -2.65, negative book value and tight liquidity ratios, which supports a cautious stance. Meyka AI rates the ticker 64.37 (Grade B, HOLD) and projects HKD 0.12, an implied downside of -29.41% from today’s price; this projection is model-driven and not a guarantee. Traders looking at intraday setups should treat volume spikes as short-term signals while longer-term investors should wait for clearer improvements in cash flow and operational metrics before adding exposure.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.